Study sedative effects on ongoing brain inflammation after severe COVID
Part of Brain & nervous system, Infections, Lungs & breathing clinical trials.
This study looks at whether a specific ICU sedative (dexmedetomidine) affects long-term inflammation in the brain after severe COVID with ARDS and deep sedation. It uses PET and MRI scans and special tracers to understand persistent inflammation and why it may last.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult (18–74 years old).
- You had COVID confirmed by a lab test (PCR) from a nose or lung sample.
- You were in the ICU for COVID-related ARDS and needed a breathing machine and deep sedation for at least 24 hours.
- You have a specific gene test result for the study tracer, or you may not be eligible.
- You can undergo PET and MRI scans, and there are no scan-related safety problems.
- You have no major exclusions like pregnancy/breast-feeding, severe kidney problems, or certain serious brain history (stroke, severe head injury, dementia with loss of independence).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding ketamine to sedation medications helps patients recover better after they no longer need a breathing machine in the hospital. Researchers want to see if it reduces confusion and speeds up healing.
This trial tests a sedative drug (dexmedetomidine) to see if it helps calm agitation in patients with moderate or severe traumatic brain injury who are on a breathing machine in the ICU. The goal is to improve comfort and recovery.
This trial tests a sedative called dexmedetomidine (vs. a placebo) in older adults on breathing machines in the ICU, to see if it helps them recover faster. It's focused on patients who are likely to need sedation for at least the next two days.
This early-phase study uses a special PET scan to look for signs of brain inflammation in people with ongoing (long-term) nervous system symptoms after COVID-19. It may help researchers understand what is driving symptoms and whether this imaging approach can detect inflammation.
This study looks at how a sleep medicine called dexmedetomidine affects thinking and memory after heart surgery. It compares cognitive outcomes over time to see if this sedation choice changes long-term brain function.
This trial tests two medicines, haloperidol and dexmedetomidine, to see which one works better for calming confusion and agitation in ICU patients who have a traumatic brain injury and are on a breathing machine. If you qualify, the study may help your doctors choose the best treatment for you.
Hear when a new Severe COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.